FAQ

What kind of staff do you employ?

We are always interested in dedicated people with skills within sale, business development, commercial research, quality/regulatory and graphics. We are measured by our standards so all our staff working with safety, quality and regulatory has worked with pharmaceuticals before, and we need these educated skills to keep our high-quality level.

 

What can I gain from working at Paranova?

If you’re interested in pharmaceuticals, you can get a broad education in all aspects of the production, thus strengthening your profile in the areas you want. We provide the settings and the responsibility, and you bring the commitment.

 

I have heard that imported products often are of lower quality to the original?

Imported products are always the same as the original. The only difference is that Paranova markets products that might have been produced for another European country; hence there can be differences in names or other markings. Sometimes differences can occur regarding excipients, e.g., coloring agents. Moreover, we act under the same regulations and laws as any other pharmaceutical company, ensuring that you get the safest and most reliable treatment for our products.

 

Are there any advantages to imported products?

Society has the most to gain from import trading. By bringing competition to the market, Paranova and its colleague companies have been able to keep prices on pharmaceuticals down, providing direct savings for patients as well as the whole of society. Without parallel importation, the bill for pharmaceuticals would have been considerably higher.

 

Is anyone allowed to import and sell pharmaceuticals?

No. We, like any other pharmaceutical company, must comply with some laws and regulations set up to make sure that all necessary documentation, production facilities, distribution and environmental aspects meet the highest of standards.

 

What is parallel trading?

Parallel trade refers to the purchase of trademarked or patented goods in one country, and the subsequent export of those goods to another country. The practice of parallel importation is driven by price differences among markets. Paranova is constantly monitoring the European market for the opportunity to import pharmaceuticals from a market with lower prices than those available in any Paranova-based country. This ultimately results in lower costs to the patient as well as to society.

 

What made import trade possible?

Thanks to articles 28 to 30 of the EC Treaty that establish the principle of free movement of goods, parallel trading became possible in the early 1990’s. These articles stipulate that no artificial barriers may restrict the free movement of goods within the EU, which should function as a single market much like a national state.

 

Why are prices on pharmaceuticals different throughout Europe?

First of all, even though Europe could be considered as one giant market, national governments control the price of products in such a way, that they sell for different prices in each country. Furthermore, since social security programs work differently in each country, pharmaceuticals are valued differently, which further adds to disparate pricing.